226 related articles for article (PubMed ID: 22706077)
1. Gemfibrozil, a lipid-lowering drug, upregulates IL-1 receptor antagonist in mouse cortical neurons: implications for neuronal self-defense.
Corbett GT; Roy A; Pahan K
J Immunol; 2012 Jul; 189(2):1002-13. PubMed ID: 22706077
[TBL] [Abstract][Full Text] [Related]
2. Gemfibrozil, food and drug administration-approved lipid-lowering drug, increases longevity in mouse model of late infantile neuronal ceroid lipofuscinosis.
Ghosh A; Rangasamy SB; Modi KK; Pahan K
J Neurochem; 2017 May; 141(3):423-435. PubMed ID: 28199020
[TBL] [Abstract][Full Text] [Related]
3. Involvement of phosphatidylinositol 3-kinase-mediated up-regulation of I kappa B alpha in anti-inflammatory effect of gemfibrozil in microglia.
Jana M; Jana A; Liu X; Ghosh S; Pahan K
J Immunol; 2007 Sep; 179(6):4142-52. PubMed ID: 17785853
[TBL] [Abstract][Full Text] [Related]
4. Gemfibrozil, a lipid-lowering drug, induces suppressor of cytokine signaling 3 in glial cells: implications for neurodegenerative disorders.
Ghosh A; Pahan K
J Biol Chem; 2012 Aug; 287(32):27189-203. PubMed ID: 22685291
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1beta interferes with signal transduction induced by neurotrophin-3 in cortical neurons.
Soiampornkul R; Tong L; Thangnipon W; Balazs R; Cotman CW
Brain Res; 2008 Jan; 1188():189-97. PubMed ID: 18036576
[TBL] [Abstract][Full Text] [Related]
6. Leptin and interleukin-1beta modulate neuronal glutamate release and protect against glucose-oxygen-serum deprivation.
Wang CH; Wang WT; Cheng SY; Hung WT; Wu TL; Hsueh CM
Curr Neurovasc Res; 2010 Aug; 7(3):223-37. PubMed ID: 20560877
[TBL] [Abstract][Full Text] [Related]
7. An anti-inflammatory property of Candida albicans β-glucan: Induction of high levels of interleukin-1 receptor antagonist via a Dectin-1/CR3 independent mechanism.
Smeekens SP; Gresnigt MS; Becker KL; Cheng SC; Netea SA; Jacobs L; Jansen T; van de Veerdonk FL; Williams DL; Joosten LA; Dinarello CA; Netea MG
Cytokine; 2015 Feb; 71(2):215-22. PubMed ID: 25461401
[TBL] [Abstract][Full Text] [Related]
8. Opposite regulation of IL-1beta and secreted IL-1 receptor antagonist production by phosphatidylinositide-3 kinases in human monocytes activated by lipopolysaccharides or contact with T cells.
Molnarfi N; Gruaz L; Dayer JM; Burger D
J Immunol; 2007 Jan; 178(1):446-54. PubMed ID: 17182583
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of Sirt1 by tyrosol suppresses apoptosis and inflammation and modulates extracellular matrix remodeling in interleukin-1β-stimulated human nucleus pulposus cells through activation of PI3K/Akt pathway.
Qi W; Ren D; Wang P; Song Z; Wu H; Yao S; Geng L; Su Y; Bai X
Int Immunopharmacol; 2020 Nov; 88():106904. PubMed ID: 32866785
[TBL] [Abstract][Full Text] [Related]
10. Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice.
Petrasek J; Dolganiuc A; Csak T; Kurt-Jones EA; Szabo G
Gastroenterology; 2011 Feb; 140(2):697-708.e4. PubMed ID: 20727895
[TBL] [Abstract][Full Text] [Related]
11. High glucose induces suppression of insulin signalling and apoptosis via upregulation of endogenous IL-1beta and suppressor of cytokine signalling-1 in mouse pancreatic beta cells.
Venieratos PD; Drossopoulou GI; Kapodistria KD; Tsilibary EC; Kitsiou PV
Cell Signal; 2010 May; 22(5):791-800. PubMed ID: 20067833
[TBL] [Abstract][Full Text] [Related]
12. The production of IL-1 receptor antagonist in IFN-beta-stimulated human monocytes depends on the activation of phosphatidylinositol 3-kinase but not of STAT1.
Molnarfi N; Hyka-Nouspikel N; Gruaz L; Dayer JM; Burger D
J Immunol; 2005 Mar; 174(5):2974-80. PubMed ID: 15728510
[TBL] [Abstract][Full Text] [Related]
13. Interferon regulatory factor 3 plays an anti-inflammatory role in microglia by activating the PI3K/Akt pathway.
Tarassishin L; Suh HS; Lee SC
J Neuroinflammation; 2011 Dec; 8():187. PubMed ID: 22208359
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection by nicotine against colchicine-induced apoptosis is mediated by PI3-kinase--Akt pathways.
Huang X; Cheng Z; Su Q; Zhu X; Wang Q; Chen R; Wang X
Int J Neurosci; 2012 Jun; 122(6):324-32. PubMed ID: 22248034
[TBL] [Abstract][Full Text] [Related]
15. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice.
Petrasek J; Bala S; Csak T; Lippai D; Kodys K; Menashy V; Barrieau M; Min SY; Kurt-Jones EA; Szabo G
J Clin Invest; 2012 Oct; 122(10):3476-89. PubMed ID: 22945633
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3 beta and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells.
Chung H; Seo S; Moon M; Park S
J Endocrinol; 2008 Sep; 198(3):511-21. PubMed ID: 18541646
[TBL] [Abstract][Full Text] [Related]
17. FGF9-induced changes in cellular redox status and HO-1 upregulation are FGFR-dependent and proceed through both ERK and AKT to induce CREB and Nrf2 activation.
Chuang JI; Huang JY; Tsai SJ; Sun HS; Yang SH; Chuang PC; Huang BM; Ching CH
Free Radic Biol Med; 2015 Dec; 89():274-86. PubMed ID: 26424114
[TBL] [Abstract][Full Text] [Related]
18. Amyloid formation disrupts the balance between interleukin-1β and interleukin-1 receptor antagonist in human islets.
Hui Q; Asadi A; Park YJ; Kieffer TJ; Ao Z; Warnock GL; Marzban L
Mol Metab; 2017 Aug; 6(8):833-844. PubMed ID: 28752047
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor-mediated production of IL-1Ra is negatively regulated by GSK3 via the MAPK ERK1/2.
Rehani K; Wang H; Garcia CA; Kinane DF; Martin M
J Immunol; 2009 Jan; 182(1):547-53. PubMed ID: 19109187
[TBL] [Abstract][Full Text] [Related]
20. A novel MEK2/PI3Kδ pathway controls the expression of IL-1 receptor antagonist in IFN-β-activated human monocytes.
Brandt KJ; Carpintero R; Gruaz L; Molnarfi N; Burger D
J Leukoc Biol; 2010 Dec; 88(6):1191-200. PubMed ID: 20837746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
